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THE FREQUENCY OF PERIPHERAL NEUROPATHY IN 
A GROUP OF HIV POSITIVE PATIENTS IN BRAZIL
Claudia Zanetti, Gilberto M. Manzano, Alberto A. Gabbai
ABSTRACT - Peripheral neuropathy is a common neurological complication occurring in asymptomatic and symptomatic stages of
HIV infection.The most common syndromes are distal symmetric polyneuropathy, inflammatory demielinating polyneuropathy, poli-
radiculopathy, mononeuropathy, mononeuropathy multiplex and autonomic neuropathy. Purpose: To evaluate the frequency of
peripheral neuropathy in a group of HIV seropositive outpatients in São Paulo, Brazil. Method: Over a period of 17 months, 49
HIV+ patients where evaluated clinically. Laboratory analysis and electroneuromyography were requested to all patients. Results:
Thirty four (69.4%) of the 49 patients had the diagnosis of peripheral neuropathy established on clinical grounds. The most com-
mon sign was impairment (97.1%) of sensibility. Thirteen (33.3%) of the 39 that were subjected to electroneuromyography had
features of peripheral neuropathy, being a sensitive-motor axonal neuropathy the most common. No abnormalities were found in
the laboratory analysis performed in 42 patients, except in four who had VDRL positive. Conclusion: A peripheral neuropathy was
frequently found upon clinical examination in our group of HIV positive individuals.
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Freqüência da neuropatia periférica no Brasil em um grupo de pacientes HIV positivo
RESUMO - A neuropatia periférica é complicação neurológica comum, podendo ocorrer nas fases assintomáticas e sintomáticas da
infecção pelo vírus da imunodeficiência humana (HIV). As síndromes mais comuns são a polineuropatia distal simétrica, polineu-
ropatia desmielinizante inflamatória, polirradiculopatia, mononeuropatia, mononeuropatia múltipla e neuropatia autonômica.
Objetivo: Avaliar a freqüência da neuropatia periférica em um grupo de pacientes HIV positivo em São Paulo, Brasil. Método: Em
um período de 17 meses, foram avaliados clinicamente 49 pacientes HIV positivos. Foram solicitados exames laboratoriais e
eletroneuromiografia (ENMG) para todos os pacientes. Resultados: Foi estabelecido o diagnóstico clínico de neuropatia periféri-
ca em 34 (69,4%) dos 49 pacientes. O sinal neurológico mais comum foi a alteração da sensibilidade (97,1%). Treze (33,3%) dos
39 pacientes que realizaram a ENMG tiveram o diagnóstico de neuropatia periférica, sendo a neuropatia sensitivo-motora axonal
o achado mais comum. Não foram encontradas alterações significativas nos exames laboratoriais (42 pacientes realizaram os exam-
es), com exceção de quatro pacientes em que o VDRL foi positivo. Conclusão: A neuropatia periférica foi um achado freqüente
no grupo de pacientes HIV positivo estudados clinicamente.
PALAVRAS-CHAVE: neuropatia periférica, HIV, SIDA.
1). This specificity reflects the distinct mechanisms of the vari-
ous types of peripheral neuropathies in HIV seropositive individ-
uals6-11.
The prevalence of peripheral neuropathy associated with
HIV-1 is estimated at 15 to 50% of patients7,12-15. But it may
be almost 100% when a pathological study is performed14,15.
Distal symmetrical polyneuropathy (DSP) is the most com-
mon peripheral nerve involvement in HIV-positive individuals3,16.
There are other forms of peripheral neuropathies in HIV-posi-
tive patients including inflammatory demyelinating polyneu-
ropathy6,17; progressive polyradiculopathy6,9; mononeuropathy
and mononeuropathy multiplex10,18; autonomic neuropathy8;
The acquired immunodeficiency syndrome (AIDS) was first
described in 1981.At that time it was reported the occurrence
of an uncommon opportunistic infection caused by
Pneumocystis carinni in a previously healthy young homosex-
ual man1. Neurological disorders in HIV patients were first re-
ported in 19822. Peripheral neuropathy is a common neuro-
logical complication associated with human immunodeficien-
cy virus type 1 (HIV-1) infection, occurring in asymptomatic
and symptomatic individuals3-5 and it can be the first mani-
festation of the disease6.The peripheral neuropathy syndromes
are somewhat specific according to the stage of the disease (Table
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and diffuse infiltrative lymphocytosis syndrome19 (Table 1).
The objective of this study was to evaluate the frequency
of peripheral neuropathy in a group of HIV-seropositive out-
patients in São Paulo, Brazil.
METHOD
Over a period of 17 months, from July 1999 to May 2000, 49 HIV-
positive patients where evaluated at the AIDS Outpatient Clinic of
the Infectious Diseases Division of the UNIFESP - Escola Paulista de
Medicina in São Paulo, Brazil.
Each patient arbitrarily recruited by the Coordinating Nurse had
a history taken and neurological examination done by the same neu-
rologist, mostly looking for the diagnosis of a peripheral neuropa-
thy.Although highly suspicious of a peripheral neuropathy, symptoms
of extremity pain, numbness, tingling and weakness were not eno-
ugh to make the diagnosis. The diagnosis was established when we
found any of the following, isolated or combined: sensory impairment,
absent deep tendon reflexes, amyotrophy and weakness. We exam-
ined thermal, tactile, pain, vibration and position sense sensory mo-
dalities.Weakness was considered diagnostic if it had a pattern com-
patible with any form of peripheral neuropathy20. Laboratory analy-
sis (glucose, CBC, BUN, creatinine, electrolytes, liver function, vita-
min B12,VDRL, HTLV 1/2) and  electroneuromyography21 were request-
ed to all patients.
The present study was approved by the ethics committee of the
UNIFESP - Escola Paulista de Medicina. Informed consent was obtained
from all patients.
RESULTS
Of the 49 patients included, 32 were male and 17 female.
The mean age was 36.88 years with a range of 21-53 years.
None of the patients had history of familial peripheral neu-
ropathy, diabetes mellitus or recent (less than 2 years) histo-
ry of alcohol abuse.Thirty four of our 49 patients (69.4%) had
diagnosis of a peripheral neuropathy. Twelve (35.3%) had
both symptoms and signs and 22 had only signs. Decreased
distal superficial sensibility was the common sign occurring
in 73.5% of the patients, one (3%) had only absent ankle jerks
and 8 (23.5%) had sensibility and tendon reflexes altered.Two
patients had only symptoms and two had sub-clinical periph-
eral neuropathy with neither symptoms nor signs - the periph-
eral neuropathy was diagnosed by the neurophysiologic study.
Thirty two (94.1%) patients were taking drugs supposed to
be neurotoxic (d4T,ddI, ddC, isoniazid)22-25.Thirty nine patients
had electroneuromyography performed. Thirteen (33.3%) of
those had features of peripheral neuropathy. The types of pe-
ripheral neuropathy are shown in Table 2. Seventy five per-
Table 1. Summary of HIV-associated peripheral neuropathies, clinical manifestations and diagnosis*.
Diagnosis HIV disease stage Clinical symptoms Neurological signs Diagnostic studies
Distal symmetric Late Dystal symmetric Stocking-glove sensory EMG: distal axono
polyneuropathy numbness, tingling loss; depressed or pathy
and burnig sensations; absent ankle reflex
paresthesias or aching
Inflammatory Early>>Late Progressive weakness; Muscle weakness; CSF: lymphocytic
demyelinating paresthesias mild sensory loss; pleocytosis
polyneuropathy areflexia (10 to 50 cells/µl;
EMG: demyelination 
Mononeuritis multiplex Early (limited) Foot or wrist drop; Multifocal cranial EMG: multifocal 
Late (progressive) facial weakness; and peripheral axonal neuropathies
focal pain neuropathies
Progressive Late Lower extremity Flaccid paraparesis; CSF: increased PMNs;
polyradiculopathy weakness; sphincter saddle distribution EMG: poliradiculopathy
dysfunction; anesthesia; depressed
paresthesias ankle and knee
reflexes
Autonomic neuropathy Early>>Late Orthostatic dizziness; Orthostatic hypotension; ECG: arrhythmias;
syncope; diarrhoea; pupillary abnormalities; blood pressure:
anhidrosis; palpitations; sweating dysfuntion; orthostatic hypotension
impotence; urinary resting tachycardia
dysfunction
CSF, cerebrospinal fluid; ECG, electrocardiography; EMG, electromyography; PMNs, polymorphonuclear leukocytes. *Reproducted from Wulff and Simpson29.
cent (six patients) of the patients who had a diagnosis of DSP
on electrophysiologic grounds were taking drugs supposed to
be neurotoxic (d4T, ddI, ddC isoniazid)22-25. Laboratory analy-
sis did not show any significant abnormalities (42 patients we-
re tested), except in four who had VDRL positive.
DISCUSSION
To our knowledge this is the first study of the frequency
of peripheral neuropathy in HIV-positive individuals in Brazil.
In accordance with others26 we found that 69.4% of our
patients had a clinical diagnosis of peripheral neuropathy,
Interestingly, 64.7% of those did not have any complaint sug-
gesting the involvement of the peripheral nervous system.That
subclinical peripheral nerve dysfunction has been described5,27
and may reach 71% of those examined28. The most common
complaints are numbness, parethesias and painful dyseste-
sias12,29. In our series the main symptom was mild distal dyses-
tesia that neither interfered with the activities of daily living
nor required specific therapy. The main neurological sign was
distal symmetric sensory alteration (in 97.1% of the patients)
in the four limbs but mainly in the feet.
Thirteen (33.3%) of our 39 patients that had eletro-
physiologic testing, had features of nerve lesion.The main eletro-
physiologic diagnosis was sensitive-motor axonal neuropathy.
In the literature DSP is responsible for 90% of the peripheral
neuropathies in HIV-infected individuals3,12,13,16,30. Its incidence
increases with advanced immunosupression and with decreased
CD4-cell counts31, and thus more frequent in the later stages
of the disease. DSP is clinically present in 10 to 35% of AIDS
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patients without known causes for their neuropathy12,13,16,32.
In advanced immunosupression (CD4<100 cells/µl) DSP has
been described in 30-80% of patients5,12,13. Sensory symp-
toms predominate, and the patients complain of numbness and
paresthesias. On neurological examination there is symmet-
ric distal sensory loss with absent ankle reflexes12,29. Electro-
physiological studies are most compatible with an axonal
neuropathy12,30, the same as we found.There is a low incidence
of DSP in pediatric HIV patients33.
We also found patients with mononeuropathy, mo-
noneuropathy multiplex and demyelinating neuropathy (Table
2).
The etiology and pathogenesis of peripheral neuropathy
associated with HIV infection is uncertain. It can be caused
by the direct or indirect action of HIV and antibody produc-
tion, or secondary to infections (CMV,MAC ), toxic effects of
certain drugs (isoniazid, vincristine, d4T, ddi, ddC), or nutrition-
al deficiencies (vitamin B12)4,7,22-26,34-36. In our study, almost all
the patients that had diagnosis of peripheral neuropathy were
taking drugs probably neurotoxic (ddi, d4t,ddC isoniazid).
Our electrophysiologic findings were much lower when
compared to our clinical neurological evaluation.The discrep-
ancy between our clinical and electrophysiologic findings is
probably do to the well known poor evaluation of thin fiber
system related to the routine nerve conduction tests37.
Peripheral neuropathy in HIV seropositive patients may be
overlooked or misdiagnosed. A discerning clinical analysis
may be helpful in the diagnosis of this common disease since
Table 2. Clinical manifestations, electroneuromyography and diagnosis.
Age HIV/AIDS Symptoms Signs ENMG Evolution Diagnosis
1 38 HIV no no axonal DSP
2 23 AIDS yes S/M axonal sub-acute DSP
3 30 AIDS yes S axonal chronic DSP
4 35 AIDS yes S/M axonal chronic DSP
5 38 AIDS no S axonal DSP
6 43 HIV yes S axonal sub-acute DSP
7 47 AIDS yes no axonal DSP
8 35 AIDS no S/M axonal DSP
9 38 AIDS yes S chronic MM
10 52 HIV yes S/M chronic MM
11 49 HIV yes S demyeliantin chronic IDP
12 39 AIDS yes S ? chronic M
13 49 HIV no no ? M
S, sensibility; M, motor; ENMG, electroneuromyography; DSP, distal symmetric polyneuropathy; IDP, inflammatory demyelinatin polyneuropathy; MM, mononeu-
ropathy multiplex; M, mononeuropathy.
the conventional electrophysiological study can underesti-
mate some cases of peripheral nerve involvement.
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